Posted Jun 1st 2009 1:50PM by Melly Alazraki
Filed under: Deals, Rumors, Bristol-Myers Squibb (BMY)

If you've been following
Elan Corp. (NYSE:
ELN) lately, you've probably come to take any story of a deal, takeover, sale with a grain of salt.
This morning, Elan shares soared over 16% after stories on
Reuters and the
Wall Street Journal over the weekend said it is in advanced talks to sell a minority stake to
Bristol-Myers Squibb (NYSE:
BMY).
Moreover, Elan was said to be in talks with a second suitor, but the status of those discussions was unclear. This, Reuters reported, could be the first move in a multi-step transaction to sell Elan outright.
While the shares are still up a healthy 12% by midday, now Bloomberg reports that according to UBS analysts,
Bristol isn't in talks to buy a stake in Elan.
Continue reading Elan: Yet another deal rumor -- Bristol eyeing a stake
Posted May 2nd 2009 2:40PM by Trey Thoelcke
Filed under: Earnings reports, Time Warner (TWX), Pfizer (PFE), Motorola (MOT), Exxon Mobil (XOM), Viacom (VIA), Revlon (REV), Netflix, Inc. (NFLX), Bristol-Myers Squibb (BMY), Domino's Pizza (DPZ), Procter and Gamble (PG), U.S. Steel (X), Under Armour'A' (UA), E*TRADE (ETFC)
Here are some highlights from this past week's earnings coverage from BloggingStocks:
Continue reading Earnings highlights: P&G, DreamWorks, E*Trade, Netflix, Under Armour, Humana and more
Posted Apr 28th 2009 10:10AM by Mark Fightmaster
Filed under: Earnings reports, Bristol-Myers Squibb (BMY)

Pharmaceutical firm
Bristol-Myers Squibb (NYSE:
BMY) announced that strong sales of Plavix and Abilify (an anti-clotting and psychiatric drug, respectively) helped
boost the company's quarterly revenue. The boost wasn't enough though, as higher taxes and a litigation charge weighed on the company's profit, pulling it 3.5% lower.
BMY's quarterly earnings totaled 32 cents per share, a penny worse than a year ago. However, earnings excluding items would have been 48 cents per share (simple math tells me that the charges were 16 cents per share). These charges included a litigation charge that helped settle a shareholder lawsuit. Quarterly revenue checked in at $5.02 billion, which was 3% higher than the first quarter of 2007. Excluding the effects of the strong dollar, BMY's sales would have increased 8%. Expectations called for higher sales of $5.13 billion, but lower per-share earnings of 47 cents per share.
Continue reading Bristol-Myers' first-quarter earnings fall
Posted Feb 25th 2009 8:56AM by Allan Halprin
Filed under: Microsoft (MSFT), Yahoo! (YHOO), General Electric (GE), Citigroup Inc. (C), Johnson and Johnson (JNJ), JPMorgan Chase (JPM), Money and Finance Today, Abbott Laboratories (ABT), AFLAC Inc (AFL), American Express (AXP), Bristol-Myers Squibb (BMY), Consolidated Edison (ED), Verizon Communications (VZ), News Corp'B' (NWS), UAL Corp (UAUA), Lilly (Eli) (LLY)
Continue reading 5% dividends you can believe in, is your pension safe? & 9 optimistic people - Today in Money 2/25
Posted Feb 11th 2009 12:20PM by Tom Taulli
Filed under: Citigroup Inc. (C), Bristol-Myers Squibb (BMY), Morgan Stanley (MS)
This week, there was some hope that we might see signs of relief in the IPO market. But, with the massive sell-off yesterday, those hopes are dimmed.
Yet, there was one deal that was able to get off the ground: Mead Johnson Nutrition (NYSE: MJN). The company, which has been a part of Bristol-Myers Squibb Co. (NYSE: BMY) since 1967, is a leader in the baby formula business.
Mead was able to price its IPO at $24, which was at the top-end of its $21-$24 round. In all, the company issued 30 million shares.
No doubt, Mead is a solid company, with about $2.6 billion in sales (last year). The company has a portfolio of over 70 products that are distributed across 50 countries.
Continue reading Mead Johnson braves the treacherous IPO waters
Posted Feb 11th 2009 8:17AM by Melly Alazraki
Filed under: Earnings reports, Sirius Satellite Radio (SIRI), Citigroup Inc. (C), JPMorgan Chase (JPM), Applied Materials (AMAT), Bank of America (BAC), Bristol-Myers Squibb (BMY), Dean Foods (DF), Research in Motion (RIMM), Goldman Sachs Group (GS), NIKE, Inc'B' (NKE), Activision Inc (ATVI), Rio Tinto plc ADS (RTP), Initial public offerings
Before the bell: Stocks to rebound, but investors remain cautious
ArcelorMittal (NYSE: MT) swung to a
surprising $2.6 billion loss in the fourth quarter -- its first ever -- as it experienced a collapse in demand and a sharp drop in prices. It wrote down $4.4 billion in pre-tax charges. The steel giant is also shedding some 9,000 workers. MT shares jumped over 6% in premarket trade.
Applied Materials (NASDAQ: AMAT) warned late Tuesday that chipmakers will spend 50% less this year for its products. The maker of semiconductor production equipment also posted a
fiscal first-quarter loss of $3 million, excluding charges, and said it will cut 14% of its workforce, or about 2,000 jobs, as well as production. AMAT shares declined some 2% in premarket trade.
Continue reading Stocks in the news: MT, AMAT, NVDA, MJN, SIRI, CS, DF, NKE, RIMM, RTP ...
Posted Feb 1st 2009 9:40AM by Trey Thoelcke
Filed under: Earnings reports, Yahoo! (YHOO), Pfizer (PFE), Home Depot (HD), McDonald's (MCD), American Express (AXP), Best Buy (BBY), Bristol-Myers Squibb (BMY), Colgate-Palmolive (CL), Texas Instruments (TXN), Valero Energy (VLO), Eaton Corp (ETN), Delta Air Lines (DAL)
Here are some highlights from this past week's earnings coverage from BloggingStocks:
Continue reading Earnings highlights: Yahoo!, McDonald's, American Express, Pfizer, Delta and others
Posted Jan 27th 2009 2:00PM by Brent Archer
Filed under: Major movement, Earnings reports, Good news, Bristol-Myers Squibb (BMY), Options, Technical Analysis
Bristol-Myers Squibb (NYSE:
BMY -
option chain) shares are headed higher today after the company said its
fourth-quarter profit came in at $1.24 billion, or 63 cents per share, on revenue of $5.25 billion.
BMY's adjusted profit of 46 cents per share easily beat analysts' projections of 41 cents per share. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on BMY.
BMY opened this morning at $22.92. So far today the stock has hit a low of $22.72 and a high of $23.44. As of 12:05, BMY is trading at $23.39, up 1.14 (5.1%). The chart for BMY looks bullish and
S&P gives BMY a positive 4 STARS (out of 5) buy ranking.
Continue reading Bristol-Myers (BMY) posts Q4 earnings above targets
Posted Jan 27th 2009 10:55AM by Eric Buscemi
Filed under: Analyst reports, Analyst upgrades and downgrades, Caterpillar (CAT), American Express (AXP), Bristol-Myers Squibb (BMY), Analyst initiations
Analyst upgrades:
- Societe Generale upgraded shares of Veolia Environment (NYSE: VE) to Buy from Hold as they believe the company's new finance chief implement additional cost savings.
- Citigroup upgraded shares of Sun Healthcare (NASDAQ: SUNH) to Buy from Hold and added the stock to their Top Picks Live List as they believe the market is pricing in a more severe Medicaid and Medicare reimbursement outlook than is probable. The firm has a $14 target on the stock.
- Calyon believes in 2010, American Express (NYSE: AXP) will have easy comps, reserve releases, and income statement leverage. The firm upgraded shares to Outperform from Underperform.
- Societe Generale (OTC: SCGLY) was upgraded to Buy from Hold at Citigroup.
- Caterpillar (NYSE: CAT) was raised to neutral from Sell at UBS.
- Goldman upgraded Biogen Idec (NASDAQ: BIIB) to Buy from Neutral and added shares to the Conviction Buy List; Goldman also added Bristol-Myers (NYSE: BMY) to the Conviction Buy List.
Continue reading Analyst upgrades, downgrades and initiations: AXP, CAT, BMY, GNK, TXCO ...
Posted Jan 27th 2009 8:31AM by Melly Alazraki
Filed under: Earnings reports, Yahoo! (YHOO), Apple Inc (AAPL), International Business Machines (IBM), Netflix, Inc. (NFLX), Citigroup Inc. (C), American Express (AXP), Bristol-Myers Squibb (BMY), Corning Inc (GLW), Verizon Communications (VZ), duPont(E.I.)deNemours (DD), Amgen Inc (AMGN), Texas Instruments (TXN), EMC Corp (EMC), Delta Air Lines (DAL)
DuPont (NYSE: DD) reported Tuesday morning, saying it
swung to a fourth-quarter loss. DuPont reported a loss of $629 million, or 70 cents per share, but excluding a restructuring charge the loss is 28 cents per share. Revenue fell 16% to $6.07 billion. Results were below analyst estimates of a loss of 24 cents per share on revenue of $6.17 billion.
Verizon Communications (NYSE: VZ) also reported Tuesday morning, saying it
earned $1.24 billion, or 43 cents a share, in the fourth quarter. On an adjusted basis, Verizon earned 61 cents a share compared to 62 cents a share a year ago. Sales were $24.6 billion. Verizon missed estimates only slightly and shares gained 1.6% in premarket trading.
Yahoo (NASDAQ: YHOO) is reporting after the close today and
analysts expect earnings of 13 cents a share for the period, on $1.4 billion in net revenue, according to FactSet Research. Shares indicated higher in premarket trading.
Continue reading Stocks in the news: DD, VZ, YHOO, AXP, TXN, IBM, SI, VMW, EMC, AMGN ...
Next Page »